Cargando…

Lactate does not activate NF-κB in oxidative tumor cells

The lactate anion is currently emerging as an oncometabolite. Lactate, produced and exported by glycolytic and glutaminolytic cells in tumors, can be recycled as an oxidative fuel by oxidative tumors cells. Independently of hypoxia, it can also activate transcription factor hypoxia-inducible factor-...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Hée, Vincent F., Pérez-Escuredo, Jhudit, Cacace, Andrea, Copetti, Tamara, Sonveaux, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602127/
https://www.ncbi.nlm.nih.gov/pubmed/26528183
http://dx.doi.org/10.3389/fphar.2015.00228
_version_ 1782394657377878016
author Van Hée, Vincent F.
Pérez-Escuredo, Jhudit
Cacace, Andrea
Copetti, Tamara
Sonveaux, Pierre
author_facet Van Hée, Vincent F.
Pérez-Escuredo, Jhudit
Cacace, Andrea
Copetti, Tamara
Sonveaux, Pierre
author_sort Van Hée, Vincent F.
collection PubMed
description The lactate anion is currently emerging as an oncometabolite. Lactate, produced and exported by glycolytic and glutaminolytic cells in tumors, can be recycled as an oxidative fuel by oxidative tumors cells. Independently of hypoxia, it can also activate transcription factor hypoxia-inducible factor-1 (HIF-1) in tumor and endothelial cells, promoting angiogenesis. These protumoral activities of lactate depend on lactate uptake, a process primarily facilitated by the inward, passive lactate-proton symporter monocarboxylate transporter 1 (MCT1); the conversion of lactate and NAD(+) to pyruvate, NADH and H(+) by lactate dehydrogenase-1 (LDH-1); and a competition between pyruvate and α-ketoglutarate that inhibits prolylhydroxylases (PHDs). Endothelial cells do not primarily use lactate as an oxidative fuel but, rather, as a signaling agent. In addition to HIF-1, lactate can indeed activate transcription factor nuclear factor-κB (NF-κB) in these cells, through a mechanism not only depending on PHD inhibition but also on NADH alimenting NAD(P)H oxidases to generate reactive oxygen species (ROS). While NF-κB activity in endothelial cells promotes angiogenesis, NF-κB activation in tumor cells is known to stimulate tumor progression by conferring resistance to apoptosis, stemness, pro-angiogenic and metastatic capabilities. In this study, we therefore tested whether exogenous lactate could activate NF-κB in oxidative tumor cells equipped for lactate signaling. We report that, precisely because they are oxidative, HeLa and SiHa human tumor cells do not activate NF-κB in response to lactate. Indeed, while lactate-derived pyruvate is well-known to inhibit PHDs in these cells, we found that NADH aliments oxidative phosphorylation (OXPHOS) in mitochondria rather than NAD(P)H oxidases in the cytosol. These data were confirmed using oxidative human Cal27 and MCF7 tumor cells. This new information positions the malate-aspartate shuttle as a key player in the oxidative metabolism of lactate: similar to glycolysis that aliments OXPHOS with pyruvate produced by pyruvate kinase and NADH produced by glyceraldehyde-3-phosphate dehydrogenase (GAPDH), oxidative lactate metabolism aliments OXPHOS in oxidative tumor cells with pyruvate and NADH produced by LDH1.
format Online
Article
Text
id pubmed-4602127
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-46021272015-11-02 Lactate does not activate NF-κB in oxidative tumor cells Van Hée, Vincent F. Pérez-Escuredo, Jhudit Cacace, Andrea Copetti, Tamara Sonveaux, Pierre Front Pharmacol Pharmacology The lactate anion is currently emerging as an oncometabolite. Lactate, produced and exported by glycolytic and glutaminolytic cells in tumors, can be recycled as an oxidative fuel by oxidative tumors cells. Independently of hypoxia, it can also activate transcription factor hypoxia-inducible factor-1 (HIF-1) in tumor and endothelial cells, promoting angiogenesis. These protumoral activities of lactate depend on lactate uptake, a process primarily facilitated by the inward, passive lactate-proton symporter monocarboxylate transporter 1 (MCT1); the conversion of lactate and NAD(+) to pyruvate, NADH and H(+) by lactate dehydrogenase-1 (LDH-1); and a competition between pyruvate and α-ketoglutarate that inhibits prolylhydroxylases (PHDs). Endothelial cells do not primarily use lactate as an oxidative fuel but, rather, as a signaling agent. In addition to HIF-1, lactate can indeed activate transcription factor nuclear factor-κB (NF-κB) in these cells, through a mechanism not only depending on PHD inhibition but also on NADH alimenting NAD(P)H oxidases to generate reactive oxygen species (ROS). While NF-κB activity in endothelial cells promotes angiogenesis, NF-κB activation in tumor cells is known to stimulate tumor progression by conferring resistance to apoptosis, stemness, pro-angiogenic and metastatic capabilities. In this study, we therefore tested whether exogenous lactate could activate NF-κB in oxidative tumor cells equipped for lactate signaling. We report that, precisely because they are oxidative, HeLa and SiHa human tumor cells do not activate NF-κB in response to lactate. Indeed, while lactate-derived pyruvate is well-known to inhibit PHDs in these cells, we found that NADH aliments oxidative phosphorylation (OXPHOS) in mitochondria rather than NAD(P)H oxidases in the cytosol. These data were confirmed using oxidative human Cal27 and MCF7 tumor cells. This new information positions the malate-aspartate shuttle as a key player in the oxidative metabolism of lactate: similar to glycolysis that aliments OXPHOS with pyruvate produced by pyruvate kinase and NADH produced by glyceraldehyde-3-phosphate dehydrogenase (GAPDH), oxidative lactate metabolism aliments OXPHOS in oxidative tumor cells with pyruvate and NADH produced by LDH1. Frontiers Media S.A. 2015-10-13 /pmc/articles/PMC4602127/ /pubmed/26528183 http://dx.doi.org/10.3389/fphar.2015.00228 Text en Copyright © 2015 Van Hée, Pérez-Escuredo, Cacace, Copetti and Sonveaux. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Van Hée, Vincent F.
Pérez-Escuredo, Jhudit
Cacace, Andrea
Copetti, Tamara
Sonveaux, Pierre
Lactate does not activate NF-κB in oxidative tumor cells
title Lactate does not activate NF-κB in oxidative tumor cells
title_full Lactate does not activate NF-κB in oxidative tumor cells
title_fullStr Lactate does not activate NF-κB in oxidative tumor cells
title_full_unstemmed Lactate does not activate NF-κB in oxidative tumor cells
title_short Lactate does not activate NF-κB in oxidative tumor cells
title_sort lactate does not activate nf-κb in oxidative tumor cells
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602127/
https://www.ncbi.nlm.nih.gov/pubmed/26528183
http://dx.doi.org/10.3389/fphar.2015.00228
work_keys_str_mv AT vanheevincentf lactatedoesnotactivatenfkbinoxidativetumorcells
AT perezescuredojhudit lactatedoesnotactivatenfkbinoxidativetumorcells
AT cacaceandrea lactatedoesnotactivatenfkbinoxidativetumorcells
AT copettitamara lactatedoesnotactivatenfkbinoxidativetumorcells
AT sonveauxpierre lactatedoesnotactivatenfkbinoxidativetumorcells